Colour Doppler Ultrasonography in the Assessment of Intratesticular Lesions: Influence of Lesion Size and Vascular Pattern
Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Design and Patients
2.2. Ultrasound Examination
2.3. Reference Standard and Diagnostic Grouping
- Neoplastic vs. non-neoplastic, where neoplastic lesions included germ cell tumours, lymphoma, leukaemia and Leydig/Sertoli cell tumours; non-neoplastic lesions included inflammatory, ischaemic/infarction-related, and developmental/benign non-neoplastic entities.
- Benign vs. malignant, based on the final histological diagnosis.
2.4. Image Review and Definitions
- (i)
- Vascularity (binary): Lesions were classified as vascularised (intralesional flow present) or avascular (no intralesional flow detected).
- (ii)
- For vascularised lesions, peripheral vascularity was recorded as present/absent. Intralesional vascular organisation was classified into mutually exclusive patterns: criss-cross (crossing vessels within the lesion) or disordered/haphazard (disruption of the normal linear vascular pattern without definite vessel crossing). A derived composite ‘disrupted’ pattern was defined as the presence of either criss-cross or disordered/haphazard intralesional organisation.
2.5. Statistical Analysis
3. Results
3.1. Study Population
3.2. CDUS Vascularity
3.3. Lesion Maximum Diameter, Volume and Vascularity
3.4. Vascular Patterns in Vascularised Lesions (n = 85)
3.4.1. Neoplastic vs. Non-Neoplastic
3.4.2. Benign vs. Malignant
3.4.3. Seminoma Versus Leydig Cell Tumour
3.4.4. Derived Composite “Disrupted” Pattern (Criss-Cross or Disordered/Haphazard)
3.5. Avascular Lesions (n = 14)
4. Discussion
4.1. Clinical Implications
4.2. Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Dogra, V.S.; Gottlieb, R.H.; Oka, M.; Rubens, D.J. Sonography of the scrotum. Radiology 2003, 227, 18–36. [Google Scholar] [CrossRef]
- Toren, P.J.; Roberts, M.; Lecker, I.; Grober, E.D.; Jarvi, K.; Lo, K.C. Small incidentally discovered testicular masses in infertile men—Is active surveillance the new standard of care? J. Urol. 2010, 183, 1373–1377. [Google Scholar] [CrossRef] [PubMed]
- Carmignani, L.; Gadda, F.; Gazzano, G.; Nerva, F.; Mancini, M.; Ferruti, M.; Bulfamante, G.; Bosari, S.; Coggi, G.; Rocco, F.; et al. High incidence of benign testicular neoplasms diagnosed by ultrasound. J. Urol. 2003, 170, 1783–1786. [Google Scholar] [CrossRef] [PubMed]
- Zuniga, A.; Lawrentschuk, N.; Jewett, M.A. Organ-sparing approaches for testicular masses. Nat. Rev. Urol. 2010, 7, 454–464. [Google Scholar] [CrossRef] [PubMed]
- Patrikidou, A.; Cazzaniga, W.; Berney, D.; Boormans, J.; de Angst, I.; Di Nardo, D.; Fankhauser, C.; Fischer, S.; Gravina, C.; Gremmels, H.; et al. European Association of Urology Guidelines on Testicular Cancer: 2023 Update. Eur. Urol. 2023, 84, 289–301. [Google Scholar] [CrossRef]
- Rocher, L.; Ramchandani, P.; Belfield, J.; Bertolotto, M.; Derchi, L.E.; Correas, J.M.; Oyen, R.; Tsili, A.C.; Turgut, A.T.; Dogra, V.; et al. Incidentally detected non-palpable testicular tumours in adults at scrotal ultrasound: Impact of radiological findings on management Radiologic review and recommendations of the ESUR scrotal imaging subcommittee. Eur. Radiol. 2016, 26, 2268–2278. [Google Scholar] [CrossRef]
- Ma, W.; Sarasohn, D.; Zheng, J.; Vargas, H.A.; Bach, A. Causes of Avascular Hypoechoic Testicular Lesions Detected at Scrotal Ultrasound: Can They Be Considered Benign? Am. J. Roentgenol. 2017, 209, 110–115. [Google Scholar] [CrossRef]
- Horstman, W.G.; Melson, G.L.; Middleton, W.D.; Andriole, G.L. Testicular tumors: Findings with color Doppler US. Radiology 1992, 185, 733–737. [Google Scholar] [CrossRef]
- Huang, D.Y.; Pesapane, F.; Rafailidis, V.; Deganello, A.; Sellars, M.E.; Sidhu, P.S. The role of multiparametric ultrasound in the diagnosis of paediatric scrotal pathology. Br. J. Radiol. 2020, 93, 20200063. [Google Scholar] [CrossRef]
- Huang, D.Y.; Alsadiq, M.; Yusuf, G.T.; Deganello, A.; Sellars, M.E.; Sidhu, P.S. Multiparametric Ultrasound for Focal Testicular Pathology: A Ten-Year Retrospective Review. Cancers 2024, 16, 2309. [Google Scholar] [CrossRef]
- Hermann, A.L.; L’Hermine-Coulomb, A.; Irtan, S.; Audry, G.; Cardoen, L.; Brisse, H.J.; Vande Perre, S.; Pointe, H.D.L. Imaging of Pediatric Testicular and Para-Testicular Tumors: A Pictural Review. Cancers 2022, 14, 3180. [Google Scholar] [CrossRef] [PubMed]
- Horstman, W.G.; Middleton, W.D.; Melson, G.L.; Siegel, B.A. Color Doppler US of the scrotum. Radiographics 1991, 6, 941–957. [Google Scholar] [CrossRef] [PubMed]
- Mostafa, T.; Labib, I.; El-Khayat, Y.; El-Rahman El-Shahat, A.; Gadallah, A. Human testicular arterial supply: Gross anatomy, corrosion cast, and radiologic study. Fertil. Steril. 2008, 90, 2226–2230. [Google Scholar] [CrossRef] [PubMed]
- Sidhu, P.S.; Sriprasad, S.; Bushby, L.H.; Sellars, M.E.; Muir, G.H. Impalpable testis cancer. BJU Int. 2004, 93, 888. [Google Scholar] [CrossRef]
- Lock, G.; Schroder, C.; Schmidt, C.; Anheuser, P.; Loening, T.; Dieckmann, K.P. Contrast-enhanced ultrasound and real-time elastography for the diagnosis of benign Leydig cell tumors of the testis—A single center report on 13 cases. Ultraschall Med. 2014, 35, 534–539. [Google Scholar] [CrossRef]
- Maxwell, F.; Savignac, A.; Bekdache, O.; Calvez, S.; Lebacle, C.; Arama, E.; Garrouche, N.; Rocher, L. Leydig Cell Tumors of the Testis: An Update of the Imaging Characteristics of a Not So Rare Lesion. Cancers 2022, 14, 3652. [Google Scholar] [CrossRef]
- Maizlin, Z.V.; Belenky, A.; Kunichezky, M.; Sandbank, J.; Strauss, S. Leydig cell tumors of the testis: Gray scale and color Doppler sonographic appearance. J. Ultrasound Med. 2004, 23, 959–964. [Google Scholar] [CrossRef]
- Bertolotto, M.; Derchi, L.E.; Secil, M.; Dogra, V.; Sidhu, P.S.; Clements, R.; Freeman, S.; Grenier, N.; Mannelli, L.; Ramchandani, P.; et al. Grayscale and color Doppler features of testicular lymphoma. J. Ultrasound Med. 2015, 34, 1139–1145. [Google Scholar] [CrossRef]
- Marko, J.; Wolfman, D.J.; Aubin, A.L.; Sesterhenn, I.A. Testicular Seminoma and Its Mimics: From the Radiologic Pathology Archives. Radiographics 2017, 37, 1085–1098. [Google Scholar] [CrossRef]
- Isidori, A.M.; Pozza, C.; Gianfrilli, D.; Giannetta, E.; Lemma, A.; Pofi, R.; Barbagallo, F.; Manganaro, L.; Martino, G.; Lombardo, F.; et al. Differential diagnosis of nonpalpable testicular lesions: Qualitative and quantitative contrast-enhanced US of benign and malignant testicular tumors. Radiology 2014, 273, 606–618. [Google Scholar] [CrossRef]
- Lock, G.; Schmidt, C.; Helmich, F.; Stolle, E.; Dieckmann, K.P. Early experience with contrast-enhanced ultrasound in the diagnosis of testicular masses: A feasibility study. Urology 2011, 77, 1049–1053. [Google Scholar] [CrossRef]
- Desmousseaux, T.; Arama, E.; Maxwell, F.; Ferlicot, S.; Hani, C.; Fizazi, K.; Lebacle, C.; Loriot, Y.; Boumerzoug, M.; Cohen, J.; et al. Ultrasound and Magnetic Resonance Imaging of Burned-Out Testicular Tumours: The Diagnostic Keys Based on 48 Cases. Cancers 2022, 14, 4013. [Google Scholar] [CrossRef] [PubMed]
- Kachramanoglou, C.; Rafailidis, V.; Philippidou, M.; Bertolotto, M.; Huang, D.Y.; Deganello, A.; Sellars, M.E.; Sidhu, P.S. Multiparametric Sonography of Hematologic Malignancies of the Testis: Grayscale, Color Doppler, and Contrast-Enhanced Ultrasound and Strain Elastographic Appearances with Histologic Correlation. J. Ultrasound Med. 2017, 36, 409–420. [Google Scholar] [CrossRef] [PubMed]
- Ruf, C.G.; Sanatgar, N.; Isbarn, H.; Ruf, B.; Simon, J.; Fankhauser, C.D.; Dieckmann, K.P. Leydig-cell tumour of the testis: Retrospective analysis of clinical and therapeutic features in 204 cases. World J. Urol. 2020, 38, 2857–2862. [Google Scholar] [CrossRef] [PubMed]
- Lewicki, A.; Freeman, S.; Jedrzejczyk, M.; Dobruch, J.; Dong, Y.; Bertolotto, M.; Dietrich, C.F. Incidental Findings and How to Manage Them: Testis- A WFUMB Position Paper. Ultrasound Med. Biol. 2021, 47, 2787–2802. [Google Scholar] [CrossRef]
- Bieniek, J.M.; Juvet, T.; Margolis, M.; Grober, E.D.; Lo, K.C.; Jarvi, K.A. Prevalence and Management of Incidental Small Testicular Masses Discovered on Ultrasonographic Evaluation of Male Infertility. J. Urol. 2018, 199, 481–486. [Google Scholar] [CrossRef]
- Bertolotto, M.; Muca, M.; Curro, F.; Bucci, S.; Rocher, L.; Cova, M.A. Multiparametric US for scrotal diseases. Abdom. Radiol. 2018, 43, 899–917. [Google Scholar] [CrossRef]
- De Zordo, T.; Stronegger, D.; Pallwein-Prettner, L.; Harvey, C.J.; Pinggera, G.; Jaschke, W.; Aigner, F.; Frauscher, F. Multiparametric ultrasonography of the testicles. Nat. Rev. Urol. 2013, 10, 135–148. [Google Scholar] [CrossRef]
- Drudi, F.M.; Maghella, F.; Martino, G.; Messineo, D.; Ciccariello, M.; Cantisani, V.; Malpassini, F.; Liberatore, M.; D’Ambrosio, F. Detection of small testicular masses in monorchid patients using US, CPDUS, CEUS and US-guided biopsy. J. Ultrasound 2016, 19, 25–28. [Google Scholar] [CrossRef]
- Luzurier, A.; Maxwell, F.; Correas, J.M.; Benoit, G.; Izard, V.; Ferlicot, S.; Teglas, J.P.; Bellin, M.F.; Rocher, L. Qualitative and quantitative contrast-enhanced ultrasonography for the characterisation of non-palpable testicular tumours. Clin. Radiol. 2018, 73, 322.e1–322.e9. [Google Scholar] [CrossRef]
- Sidhu, S.P.; Yusuf, T.G.; Sellars, E.M.; Deganello, A.; Fang, C.; Huang, H.Y.D. A review of multiparametric ultrasound imaging in the clinical setting: Scrotal contents. Abdom. Radiol. 2024, 50, 1363–1375. [Google Scholar] [CrossRef]
- Sidhu, P.S.; Cantisani, V.; Dietrich, C.F.; Gilja, O.H.; Saftoiu, A.; Bartels, E.; Bertolotto, M.; Calliada, F.; Clevert, D.A.; Cosgrove, D.; et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall Med. 2018, 39, e2–e44. [Google Scholar] [CrossRef]







| Characteristic | Overall (n = 99) | Benign (n = 31) | Malignant (n = 68) |
|---|---|---|---|
| Age, years (mean; median) | 38.25 ± 12.54; 35 (19–79) | 40.00 ± 11.94; 38 (19–74) | 37.46 ± 12.82; 35 (20–79) |
| Side (lesion laterality) | |||
| Left | 53 (53.5) | 15 (48.4) | 38 (55.9) |
| Right | 46 (46.5) | 16 (51.6) | 30 (44.1) |
| Greyscale ultrasound features | |||
| Margins | |||
| Circumscribed/well-defined | 79 (79.8) | 21 (67.7) | 58 (85.3) |
| Other/poorly defined | 20 (20.2) | 10 (32.3) | 10 (14.7) |
| Echogenicity | |||
| Hypoechoic | 63 (63.6) | 23 (74.2) | 40 (58.8) |
| Other | 36 (36.4) | 8 (25.8) | 28 (41.2) |
| Marked heterogeneity (present) | 33 (33.3) | 6 (19.4) | 27 (39.7) |
| Microlithiasis (present) | 18 (18.2) | 3 (9.7) | 15 (22.1) |
| Macrocalcification (present) | 6 (6.1) | 0 (0.0) | 6 (8.8) |
| Group | Histology | n | % of Total (n = 99) | % Within Group |
|---|---|---|---|---|
| Malignant neoplastic | Classical seminoma | 34 | 34.3 | 50 |
| Mixed germ cell tumour | 12 | 12.1 | 17.6 | |
| Malignant teratoma | 8 | 8.1 | 11.8 | |
| Acute myeloid leukaemia (AML) | 4 | 4 | 5.9 | |
| Embryonal carcinoma | 2 | 2 | 2.9 | |
| Lymphoma | 2 | 2 | 2.9 | |
| Rhabdomyosarcoma | 1 | 1 | 1.5 | |
| Metastasis—prostate | 1 | 1 | 1.5 | |
| Combined germ cell tumour (seminoma 70%, yolk sac 20%, embryonal 10%) | 1 | 1 | 1.5 | |
| AML with myelodysplasia | 1 | 1 | 1.5 | |
| Metastasis—adenocarcinoma from the bowel | 1 | 1 | 1.5 | |
| Burnt-out tumour | 1 | 1 | 1.5 | |
| Subtotal malignant neoplastic | 68 | 68.7 | 100 | |
| Benign neoplastic | Leydig cell tumour with low malignant potential | 14 | 14.1 | 100 |
| Subtotal benign neoplastic | 14 | 14.1 | 100 | |
| Non-neoplastic | Acute segmental infarction | 4 | 4 | 23.5 |
| Orchitis | 3 | 3 | 17.6 | |
| Fibrous scarring | 2 | 2 | 11.8 | |
| Venous infarction and chronic ischaemia | 1 | 1 | 5.9 | |
| Complete infarction | 1 | 1 | 5.9 | |
| Atrophy and pyocele | 1 | 1 | 5.9 | |
| Abscess | 1 | 1 | 5.9 | |
| Simple tunica cyst | 1 | 1 | 5.9 | |
| Splenic heterotopia | 1 | 1 | 5.9 | |
| No pathological abnormality identified (orchiectomy) | 2 | 2 | 11.8 | |
| Subtotal non-neoplastic | 17 | 17.2 | 100 | |
| Total | Total | 99 | 100 |
| Comparison/Group | Avascular (No Flow) | Vascularised (Flow Present) | Fisher’s Exact p | Odds Ratio (95% CI) |
|---|---|---|---|---|
| Neoplastic status | ||||
| Non-neoplastic (n = 17) | 10 (58.8%) | 7 (41.2%) | ||
| Neoplastic (n = 82) | 4 (4.9%) | 78 (95.1%) | <0.001 | 27.86 (6.91–112.26) |
| Malignancy status | ||||
| Benign (n = 31) | 10 (32.3%) | 21 (67.7%) | ||
| Malignant (n = 68) | 4 (5.9%) | 64 (94.1%) | 0.001 | 7.62 (2.16–26.86) |
| Avascular (n = 14) | Vascularised (n = 85) | p Value | |
|---|---|---|---|
| Lesion size summary by vascularity status | |||
| Maximum diameter (mm) | Median 18.5 [11.0–35.5]; range 6–54 Mean 23.29 ± 15.81 | Median 21.0 [10.5–36.0]; range 2–100 Mean 26.31 ± 21.00 | 0.888 * |
| Univariable logistic regression (outcome: vascularised vs. avascular) | |||
| Predictor (per unit) | OR | 95% CI | p value |
| Maximum diameter (per 1 mm) | 1.008 | 0.978–1.040 | 0.605 |
| Pattern (Present) | Group 1, n/N (%) | Group 2, n/N (%) | Fisher’s Exact p | OR (95% CI) |
|---|---|---|---|---|
| Panel A: Neoplastic vs. non-neoplastic (vascularised lesions only) | ||||
| Peripheral vascularity | Neoplastic (n = 78): 9/78 (11.5) | Non-neoplastic (n = 7): 0/7 (0.0) | 1.000 | 2.05 (0.11–38.85) † |
| Composite “disrupted” pattern | Neoplastic (n = 78): 70/78 (89.7) | Non-neoplastic (n = 7): 3/7 (42.9) | 0.007 | 11.67 (2.21–61.73) |
| Panel B: Benign vs. malignant (vascularised lesions only) | ||||
| Peripheral vascularity | Benign (n = 21): 3/21 (14.3) | Malignant (n = 64): 6/64 (9.4) | 0.683 | 0.62 (0.14–2.74) |
| Composite “disrupted” pattern | Benign (n = 21): 14/21 (66.7) | Malignant (n = 64): 59/64 (92.2) | 0.008 | 5.90 (1.63–21.37) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Bartlett, E.C.; Huang, D.Y.; Piorkowska, M.; Sellars, M.E.; Clarke, J.L.; Sriprasad, S.; Muir, G.H.; Quinlan, D.J.; Sidhu, P.S. Colour Doppler Ultrasonography in the Assessment of Intratesticular Lesions: Influence of Lesion Size and Vascular Pattern. Cancers 2026, 18, 741. https://doi.org/10.3390/cancers18050741
Bartlett EC, Huang DY, Piorkowska M, Sellars ME, Clarke JL, Sriprasad S, Muir GH, Quinlan DJ, Sidhu PS. Colour Doppler Ultrasonography in the Assessment of Intratesticular Lesions: Influence of Lesion Size and Vascular Pattern. Cancers. 2026; 18(5):741. https://doi.org/10.3390/cancers18050741
Chicago/Turabian StyleBartlett, Emily C., Dean Y. Huang, Marta Piorkowska, Maria E. Sellars, Jane L. Clarke, Seshadri Sriprasad, Gordon H. Muir, Daniel J. Quinlan, and Paul S. Sidhu. 2026. "Colour Doppler Ultrasonography in the Assessment of Intratesticular Lesions: Influence of Lesion Size and Vascular Pattern" Cancers 18, no. 5: 741. https://doi.org/10.3390/cancers18050741
APA StyleBartlett, E. C., Huang, D. Y., Piorkowska, M., Sellars, M. E., Clarke, J. L., Sriprasad, S., Muir, G. H., Quinlan, D. J., & Sidhu, P. S. (2026). Colour Doppler Ultrasonography in the Assessment of Intratesticular Lesions: Influence of Lesion Size and Vascular Pattern. Cancers, 18(5), 741. https://doi.org/10.3390/cancers18050741

